Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, October 25, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Diligent Pharma, Inc. Announces Completion of $8.27 Million Series A Financing Raised
Life Sciences Times
-
May 15, 2023
0
Venture Capital
NewBiologix Launches with $50M to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies
Life Sciences Times
-
May 11, 2023
0
Venture Capital
Amino Health Secures $80 Million in Financing to Accelerate Growth and Product Innovation
Life Sciences Times
-
May 11, 2023
0
Venture Capital
Scientist.com Acquires Labs Explorer and Continues Rapid Expansion into European Research Market
Life Sciences Times
-
May 11, 2023
0
Venture Capital
NYBC Ventures Launches $50M Fund to Accelerate Innovations in Blood and Cellular Therapies
Life Sciences Times
-
May 11, 2023
0
Venture Capital
Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera
Life Sciences Times
-
May 9, 2023
0
Venture Capital
Morgan Health Announces $25 Million Investment in Kindbody, Expanding Access to Fertility and Family-Building Care
Life Sciences Times
-
May 1, 2023
0
Venture Capital
Pulse Biosciences Announces $65 Million Private Placement
Life Sciences Times
-
May 1, 2023
0
Venture Capital
Therini Bio Raises $36M Series A Financing to Develop Fibrin-Targeted Therapies for Neurodegenerative and Retinal Diseases
Life Sciences Times
-
April 27, 2023
0
Venture Capital
Seres Therapeutics Announces $250 Million Debt Financing with Oaktree
Life Sciences Times
-
April 27, 2023
0
Venture Capital
Zura Bio Announces $80 Million Financing and the Licensing of Tibulizumab (ZB-106), a Potential First-in-Class anti-IL-17 and anti-BAFF Dual Antagonist for Autoimmune Diseases
Life Sciences Times
-
April 27, 2023
0
Venture Capital
ODDITY Invests $100M to Bring Pharma’s AI Based Molecule Discovery Technology to Beauty and Wellness.
Life Sciences Times
-
April 27, 2023
0
1
...
46
47
48
...
115
Page 47 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026